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The constitutive reuptake of albumin from the glomerular filtrate
by receptor-mediated endocytosis is a key function of the renal
proximal tubules. Both the Cl channel ClC-5 and the Na-H
exchanger isoform3 are critical components of themacromolecular
endocytic complex that is required for albumin uptake, and there-
fore the cell-surface levels of these proteins may limit albumin
endocytosis. This study was undertaken to investigate the potential
roles of the epithelial PDZ scaffolds, Na-H exchange regulatory
factors, NHERF1 and NHERF2, in albumin uptake by opossum kid-
ney (OK) cells. We found that ClC-5 co-immunoprecipitates with
NHERF2 but not NHERF1 from OK cell lysate. Experiments using
fusion proteins demonstrated that this was a direct interaction
between an internal binding site in the C terminus of ClC-5 and the
PDZ2module of NHERF2. In OK cells, NHERF2 is restricted to the
intravillar region while NHERF1 is located in the microvilli. Silenc-
ing NHERF2 reduced both cell-surface levels of ClC-5 and albumin
uptake. Conversely, silencing NHERF1 increased cell-surface levels
of ClC-5 and albumin uptake, presumably by increasing the mobil-
ity of NHE3 in the membrane and its availability to the albumin
uptake complex. Surface biotinylation experiments revealed that
both NHERF1 and NHERF2 were associated with the plasmamem-
brane and thatNHERF2was recruited to themembrane in the pres-
ence of albumin. The importance of the interaction between
NHERF2 and the cytoskeleton was demonstrated by a significant
reduction in albumin uptake in cells overexpressing an ezrin bind-
ing-deficient mutant of NHERF2. Thus NHERF1 and NHERF2 dif-
ferentially regulate albumin uptake by mechanisms that ultimately
alter the cell-surface levels of ClC-5.
The epithelial cells of the renal proximal tubule reabsorb large
amounts of water, Na, Cl, HCO3, PO4, glucose, and amino acids
from the glomerular filtrate (1). In addition to ions and small molecules,
proteins such as albumin cross the glomerular barrier (2). Under normal
conditions the tubular concentration of albumin in humans is4mg/li-
ter (3). This equates to 720mg of albumin entering the kidneys each day
and yet30 mg of albumin is excreted per day, with the rest is consti-
tutively reabsorbed in the proximal tubule by receptor-mediated endo-
cytosis (2). This process involves the binding of albumin to themegalin/
cubulin scavenger receptor, internalization of the complex, subsequent
dissociation of the albumin from the receptor in the endosomes (2, 4),
and finally degradation of albumin to its constitutive amino acids in
the lysosomes, while megalin/cubulin is recycled back to the cell
membrane (5).
A series of recent studies suggest that the endocytosis of albumin
requires a macromolecular complex that includes the receptor, mega-
lin/cubulin, the Cl channel ClC-5, the Na-H exchanger isoform 3
(NHE3),2 and the v-typeH-ATPase (2, 6, 7). The absolute requirement
formegalin/cubulin is evident from the severe proteinuria seen inmega-
lin/cubulin-deficient dogs (8). The functional basis for the obligate role
of NHE3 in albumin uptake is less clear and may involve initiating the
acidification of the nascent endosome by the electroneutral exchange of
endosomal Na for cytosolic H (9, 10) or inhibiting fusion of the early
endosome (10). This is demonstrated by reduced albumin uptake in the
OK cell line when NHE3 is inhibited and the abolition of albumin
uptake in NHE3-deficient OK cells (9, 11). These data are comple-
mented by the finding of elevated levels of urinary protein in NHE3
knock-out mice (12). The situation with ClC-5 is more precise, because
defective ClC-5 in Dent’s disease patients results in proteinuria (13) as
does ClC-5 knock-out in mice (14, 15). The proteinuria was hypothe-
sized to result from reduced albumin uptake due to the lack of an anion
shunt and failure of the endosomes to acidify (15), although new data
showing that ClC-5 functions as a Cl/H antiporter questions the role
of ClC-5 as an anion shunt (16, 17). Another possible role played by
ClC-5 is in mediating the protein-protein interactions that are involved
in the assembly of the endocytic complex (6). This hypothesis is sup-
ported by data from the proximal tubules of ClC-5 knock-out mice and
patients with Dent’s disease where megalin is down-regulated and the
v-H-ATPase is mistrafficked to the basolateral domain (18, 19). It is
also clear that albumin uptake involves actin cytoskeleton acting as an
anchoring point for the endocytic complex (20–22), because disruption
of the cytoskeleton abolishes albumin uptake (21, 23). The presence of
albumin causes actin clusters to form at the apical membrane that co-
localize with the sites of albumin uptake (21). We have also shown that
an interaction between ClC-5 and the actin-depolymerizing protein
cofilin is required for albumin uptake (22). Thus, although significant
progress has been made in identifying both ClC-5 and NHE3, as essen-
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tial and therefore rate-limiting components in albumin uptake, we have
little insight into the protein-protein interactions that direct the forma-
tion of the endocytic complex and anchor it to the cytoskeleton.
One class of proteins that is critically involved in the assembly of
macromolecular complexes are PDZ module-containing scaffolds (24).
The first PDZ scaffold protein described for an epithelial transporter
was the Na/H exchanger regulatory factor (NHERF, NHERF1, or
EBP50) that was found to mediate the regulation of NHE3 by cAMP in
the proximal tubule (25). Subsequently, a second protein, NHERF2 (or
E3KARP), was also identified as a binding partner for NHE3 (26).
NHERF1 and NHERF2 contain tandem PDZmodules and a C-terminal
ezrin binding domain that can anchor the complex to the underlying
actin cytoskeleton (24). Typically, PDZ modules bind to PDZ binding
motifs in the extreme C terminus of target proteins, but they can also
bind to internal sequences and lipids (27) as well as also forming homo-
and heterodimers (28).
NHERF1 andNHERF2 share only 44%homologywithmost sequence
conservation in their PDZmodules (26). Significantly, they display pro-
nounced spatial heterogeneity in the proximal tubule with reports in
both mouse and human (29–31) showing that NHERF1 is strongly
expressed in the microvilli, while NHERF2 is primarily localized at the
base of the microvilli in the vesicle-rich domains (29–31). NHERF pro-
teins clearly have the capacity to nucleate the formation of functional
complexes at the plasmamembrane (30, 32) and restrict the mobility of
plasmamembrane proteins, such as NHE3 (33, 34). Thus the organized
subcellular distribution of NHERF1/2 is speculated to play a role in the
specific interactions that mediate the physiological regulation of trans-
porter function (31). The current study was therefore undertaken to
investigate the potential involvement of NHERF1/2 in albumin uptake
and whether this involved interactions with ClC-5, a key component of
the albumin endocytic complex.
EXPERIMENTAL PROCEDURES
Materials and Antibodies—Anti-NHERF1 (35), anti-NHERF2 (20)
and anti-ClC-5 antibody have been previously described (22, 36).
Anti-GST conjugated to horseradish peroxidase (HRP) was provided by
AmershamBiosciences, and anti-MBP conjugated toHRPwas provided
by New England Biolabs. Secondary antibody conjugated to rhodamine
was obtained from Calbiochem. Secondary antibodies conjugated to
HRP were from Pierce.
Cell Culture—The opossum kidney (OK) cell line was obtained from
Dr. Daniel Markovich (University of Queensland), and the cells were
maintained inDMEM/Ham’s F-12 (DMEM/F-12)media supplemented
with 10% fetal bovine serum, penicillin/streptomycin and incubated at
37 °C in 5% CO2. For experimental protocols, OK cells were seeded at
confluence and grown for 5 days. Two days prior to experimentation,
cells were incubated inDMEM/F-12with 5mMglucosemedium lacking
serum. HEK293 cells were maintained in DMEMmedia supplemented
with 10% fetal bovine serum, penicillin/streptomycin, and incubated at
37 °C in 5% CO2.
Characterization of NHERF2 in OK Cells—RNA was extracted from
OK cells and HEK-293 (control) cells using TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. Total RNA (2 g) was
treated with DNase (Promega) and then reverse-transcribed using Super-
script III (Invitrogen).NHERF2was amplified using primers describedpre-
viously (37). ForWestern blot detection, Triton X-100-soluble fractions of
OKcells (40g)were separatedon a 10%SDS-PAGEgel and transferred to
anitrocellulosemembrane.NHERF2was thendetectedusing a rabbit poly-
clonal anti-NHERF2 antibody (1:10,000 dilution). The cellular distribution
of NHERF2 was determined by confocal microscopy using the NHERF2
antibody (1:100) and a secondary anti-rabbit antibody conjugated to rho-
damine (Calbiochem, 1:40).
GST Pull-down Assay—Generation of the GST fusion proteins con-
taining NHERF1 and NHERF2, the individual PDZ domains NHERF2
PDZ1 (PDZ1), NHERF2 PDZ2 (PDZ2) and NHERF2 C terminus
(C-term) and the C terminus of ClC-5 (GST-ClC-5) have been previ-
ously described (19, 34). The GST fusion proteins were produced as
described previously using the GST purification kit (Amersham Bio-
sciences) following the manufacturer’s instructions (22). In brief, the
bacteria were induced to produce GST fusion protein with IPTG (1
mM), cells lysed and the GST fusion protein purified using a glutathione
Sepharose 4B column. For the pulldown assay, 50 g of GST or GST
fusion protein were incubated with glutathione-Sepharose 4B beads
(Amersham Biosciences) for 3 h at 4 °C. The beads were then washed,
centrifuged, and incubated with 1 mg of lysate from OK cells at 4 °C
for 18 h. The beads were washed repeatedly, and the samples were
eluted into Laemmli gel sample buffer. Samples were resolved on SDS-
PAGE gel and transferred to nitrocellulose membranes. Western blot-
ting was performed using the appropriate antibody, and the blots were
detected using secondary antibodies conjugated to HRP and the Super-
Signal West Pico Substrate (Pierce). In addition, 50 g of GST fusion
proteins was transferred to a nitrocellulose membrane and probed with
anti-GST conjugated to HRP to demonstrate an equal amount of pro-
tein in the reaction. The protein was detected using the SuperSignal
West Pico Substrate (Pierce).
MBPPull-downAssay—TheC terminus of ClC-5was subcloned into
pMAL-c2x (New England Biolabs). A mutant that lacked the final five
amino acids (D741X) was generated using site-directed mutagenesis as
described previously (38). Both plasmids were used to transform BL-21
component cells. The fusion protein containing the C terminus of
ClC-5 fused to MBP (MBP-ClC-5) and the D741X mutant (MBP-
PDZ) were induced with isopropyl 1-thio--D-galactopyranoside (1
mM), the cells were lysed, and the fusion protein was isolated using an
amylose column. For the direct interaction assay, 5 g of MBP-ClC-5,
MBP-PDZ, or MBP alone as a control was incubated with amylose
beads for 3 h at 4 °C. GST-NHERF2 (300 ng) was then added to the
complex, and the mixture was incubated overnight. The complex was
pelleted andwashed four times with buffer containing 1%TritonX-100.
The samples were suspended in Laemmli gel sample buffer, separated
on a 10% SDS-PAGE gel, and transferred to nitrocellulose membranes.
Western blotting was performed using the anti-NHERF2 antibody, and
the blots were detected using secondary antibodies conjugated to HRP
and the SuperSignal West Pico Substrate (Pierce). As a further control,
50 g of MBP fusion proteins was transferred to a nitrocellulose mem-
brane and probed with anti-MBP conjugated to HRP to demonstrate an
equal amount of protein in the reaction. The protein was detected using
the SuperSignal West Pico Substrate (Pierce).
Immunoprecipitation—Protein-A-agarose beads (Roche Applied Sci-
ence)wereused for immunoprecipitation experimentsusing themanufac-
turer’s protocol. Briefly, OK cells were lysed in lysis buffer (50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, and Complete protease
inhibitors (Roche Applied Science)). 50 l of Protein-A-agarose was
incubated with the lysate for 3 h at 4 °C. The pre-cleared lysate was then
incubated with anti-NHERF1 or anti-NHERF2 antibodies at 4 °C over-
night. Protein-A-agarose (50 l) was added to the sample, and the mix-
ture was incubated for 3 h at 4 °C. The pelleted beads were then washed
three times in 500 l of wash buffer (50 mM Tris-HCl, pH 7.5, 500 mM
NaCl, 0.1%TritonX-100), and the sampleswere eluted into Laemmli gel
sample buffer, separated on a 5% SDS-PAGE gel, and then transferred to
nitrocellulose membranes. Western blotting was performed with anti-
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ClC-5 antibody as previously described (22). As a further control, 50g
of OK cell lysate was resolved on SDS-PAGE gel transferred to a nitro-
cellulose membrane and probed with anti-ClC-5, anti-NHERF1, and
anti-NHERF2 to demonstrate equal loading of the lysate in each
reaction.
Electrophysiological Recording of ClC-5 Currents in Xenopus oo-
cytes—Capped RNA (cRNA) transcripts encoding the full-length ClC-5
and NHERF2 were synthesized using the mMESSAGEmMACHINE in
vitro transcription kit (Ambion). Xenopus laevis stage V–VI oocytes
were treated with collagenase (Type I, Sigma) for defolliculation. The
oocytes were then injected with cRNA for ClC-5 (5 ng/oocyte) in the
absence and presence of the cRNA encodingNHERF2 (10 ng/oocyte) or
water as a control. The oocytes were incubated at 18 °C in ND96 solu-
tion (96 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM HEPES,
5mMpyruvic acid, and 50g/ml gentamicin, pH 7.5) prior to recording.
Three days after cRNA injection, membrane currents were recorded
from oocytes using the two-electrode (virtual ground circuit) voltage
clamp technique using microelectrodes filled with 3 M KCl. All record-
ings were made at room temperature (20–23 °C) using ND96 solution.
Using a GeneClamp 500B amplifier and pCLAMP 8 software (Axon
Instruments Inc., Union City, CA), data were low pass-filtered at 1 kHz,
digitized at 10 kHz, and leak-subtracted on-line using a -P/8 protocol
and analyzed offline. Inward Cl currents mediated by ClC-5 were gen-
erated by holding the cells at70 mV and applying 100-ms step depo-
larizations to membrane potentials from30 mV to80 mV. Statisti-
cal significance was determined using an unpaired t test (95%
confidence interval).
Electron Microscopy—Cells were fixed with 8% (w/v) paraformalde-
hyde in phosphate-buffered saline and then processed for frozen sec-
tioning according to published methods (39). Thawed sections were
labeled with antibodies to NHERF1 or NHERF2 followed by 10 nm
Protein A-gold (University of Utrecht).
Transfections and Plasmid DNA—OK cells were transiently transfected
with either a wild-type-NHERF1, NHERF2, dominant negative-NHERF1
lacking the ezrin binding domain (NHERF-1EZR), NHERF2 (NHERF-
1EZR), or control pCDNA3 plasmid. The ezrin binding domain links
the NHERF proteins to the actin cytoskeleton (24). In addition, cells
were transfected with the silencing RNA construct pSHAG (40) con-
taining OK NHERF1-specific sequences (EBP114: 5-CCAACGAGC-
CGGGCTCCACCAGGCCGGAT-3 and EBP248: 5-GTCGACCAC-
CAGCAGGCGCACGGCGTTG-3) and human NHERF2-specific
sequences (pSHAG 274: 5-ACGGCGTCAACGTGGAGGGCGA-
GACGCA-3 and pSHAG 361: 5-CCGAAGCCAGACTGGGCACA-
CACCGGCAG-3) or the control vector (pSHAG-FF that contains
small interference RNA against firefly luciferase). All transfections were
performed using Fugene (Roche Applied Science) or Effectene (Qia-
gen), following the manufacturers’ protocol.
AlbuminUptake—Weused standard albumin uptakemethods inOK
cells, a cell line commonly used for the study of proximal tubule albumin
uptake (22, 41, 42). For transfected cells, control (mock transfected with
vector) OK cells or cells transfected with the various constructs were
grown in 48-well plates for 7 days (21, 22, 36, 43). To study the effect of
cAMP on albumin uptake, cells were preincubated with 8-Br-cAMP
(100M) for 1 h. To determine albumin uptake, cells were exposed to 50
g/ml albumin conjugated to Texas Red (Molecular Probes) under the
different conditions for 120min (22). As a control to determine the level
of endocytosis dependent on the intact cytoskeleton, some cells were
pre-treated with cytochalasin B (1.5 M) for 60 min before exposure to
TR-albumin. Nonspecific binding was determined in cells exposed to
albumin for 1min. At the end of the uptake period, cells were washed in
HEPES buffer, pH 6 at 4 °C, and then lysed in MOPS buffer (20 mM
MOPS with 0.1% Triton X-100). The TR-albumin fluorescence was
determined using a Fusion spectrophotometer (Hewlett Packard, Black-
burn, Victoria, Australia) at 580 nm excitation and 630 nm emission
wavelengths. TR-albumin uptake was standardized to total cellular pro-
tein, and the amount of fluorescence per microgram of cellular protein
was adjusted for background.
Cell-surface Biotinylation—Cell-surface biotinylation was used to
detect the levels of ClC-5 in the plasma membrane and the levels of
NHERF1 and NHERF2 associated with the plasmamembrane. OK cells
were transiently transfectedwith pSHAG-FF, EBP114, EBP248, pSHAG
274, and pSHAG361 as described above. The cell-surface proteins were
biotinylated as described previously (36). Briefly, confluent OK cell
monolayers were washed three times in cold phosphate-buffered saline
then biotinylated with 1.22 mg/ml EZ-Link NHS-SS-Biotin (Pierce) at
4 °C with gentle agitation. Monolayers were washed three times in cold
phosphate-buffered saline, and the cells were lysed in lysis buffer. The
biotinylated proteins were isolated by binding to ImmunoPure immo-
bilized streptavidin (Pierce) for 15 min on ice. The beads were pelleted,
and the supernatant that contained the cytoplasmic (unbiotinylated)
fraction was recovered by centrifugation at 4500  g for 6 min at 4 °C.
The membrane (biotinylated) fraction was washed, and the pellet was
suspended in Laemmli sample buffer. An equal protein amount of the
biotinylated fractions and whole cell fractions were resolved on a 5%
SDS-PAGE gel, and then transferred to nitrocellulose.Western blotting
was performed with the anti-ClC-5, anti-NHERF1, and anti-NHERF2
antibodies as described above.
FIGURE1.NHERF2 isendogenouslyexpressed inOKcells.A, reverse transcription-PCR
showing the presence of a 330-bp product that corresponds to NHERF2 in OK and con-
trol (HEK) cells, as well as the -actin control. B, Western blot analysis showing a single
band of 43 kDa corresponding to the NHERF2 protein in OK cells. C, X-Y confocal scan
showing NHERF2 at the plane of the apical membrane (scale bars  10 m). D, X-Z
confocal scan showing that NHERF-2 is predominantly cytosolic at the apical domain of
OK cells.
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Confocal Microscopy—Albumin uptake in OK cells transfected with
the silencing RNA against NHERF1/2 was performed as previously
described (21). Briefly, cells were seeded onto glass coverslips, tran-
siently transfected with the NHERF-silencing RNA plasmids and GFP.
Confluent monolayers of OK cells were exposed to 1 mg/ml TR-albu-
min for 20 min. All cells were fixed in 4% paraformaldehyde and were
analyzed by confocal microscopy. Cells were analyzed by confocal
microscopy using a Zeiss LSM 510 Meta confocal microscope with
Plan-Apochromat 63, 1.4 numerical aperture objective. GFP was
excited at 488 nm, and emission was measured at 515 	 15 nm. TR-
albumin was excited at 543 nm and emission measured at 570 nm.
Quantification of Results and Statistical Analysis—Densitometric
analysis of the Western blot data was performed using Fujifilm Sci-
enceLab 99 Image Gauge (version 3.3). Statistical analyses of the data
were performed using a two-tailed Student’s paired t test or analysis
of variance where appropriate with a p value of 0.05 consider-
ed significant.
RESULTS
Distribution of NHERF2 inOKCells—It has been reported previously
that some clones of OK cells express NHERF1 but not NHERF2 (30, 37,
44). It was therefore essential to confirm that the OK cells used in the
current study did express NHERF2. Reverse transcription-PCR using
NHERF2-specific primers (37) performed on mRNA isolated from OK
cells clearly showed the presence of the message for NHERF2 (Fig. 1A),
and Western blot analysis on cell lysate demonstrated the presence of
NHERF2 protein (Fig. 1B). Finally, confocal analysis of confluent OK
cells revealed abundant cytosolic staining for NHERF2 that was more
pronounced at the apical domain (Fig. 1, C andD), a distribution that is
similar to that reported for NHE3 and ClC-5 (45, 46).
ClC-5 Interacts with NHERF2 but Not NHERF1—To demonstrate
in vivo and in vitro interactions between ClC-5 and NHERF1/2 we first
performed co-immunoprecipitations using NHERF1- and NHERF2-
specific antibodies. We found that NHERF2 but not NHERF1 antibody
precipitated ClC-5 from OK cell lysates (Fig. 2A). Lysate controls
showed equal amounts of NHERF1, NHERF2, and ClC-5 in the reac-
tions (Fig. 2B). This interaction was confirmed by using GST fusion
proteins of NHERF1/2 to show that only NHERF2 could pull down
ClC-5 from OK cell lysate (Fig. 2C ). Fusion protein controls showed
equal amounts of GST, GST-NHERF1, and GST-NHERF2 in the reac-
tions (Fig. 2D). Further experiments were then performed with GST
fusion proteins expressing the individual functional domains (PDZ1,
PDZ2, and C terminus) of NHERF2 to show that ClC-5 bound to the
second PDZ domain (Fig. 2E). Again, fusion protein controls showed
FIGURE 2. ClC-5 interacts with NHERF2 in vitro
and in vivo. A, Western blot of NHERF1/2 co-im-
munoprecipitates probed with anti-ClC-5 anti-
body showing that ClC-5 binds toNHERF2 andnot
NHERF1 in vivo. Thehighmolecularweightband is
a putative ClC-5 dimer. B, Western blot of ClC-5,
NHERF1, and NHERF2 showing equal amounts of
these proteins in each reaction. C, Western blot of
OK cell lysate incubated with GST-NHERF1/2
shows that ClC-5 binds to NHERF2 and not
NHERF1 in vitro. D, Western blot of GST, GST-
NHERF1, and GST-NHERF2 demonstrates equal
amounts of the fusion proteins in the reaction. E,
GST pull-down assays with NHERF2 functional
domains shows that ClC-5 binds to PDZ of
NHERF2. F, Western blot of GST, GST-PDZ1, GST-
PDZ2, and GST-C-term showing equal amounts of
the fusion proteins in the reaction. G, MBP, MBP-
ClC-5, and MBP-PDZ were incubated with GST-
NHERF2. Both MBP-ClC-5 and MBP-PDZ bind to
GST-NHERF2. H, Western blot of MBP, MBP-ClC-5,
and MBP-PDZ showing equal amounts of the
fusion proteins in the reaction.
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equal amounts of GST, GST-PDZ 1, GST-PDZ2, and GST-C-term in
the reactions (Fig. 2F ). Protein-protein interactions detected using
GST-pull-downs in cell lysates may occur as a result of accessory pro-
teins. Therefore, to demonstrate a direct interaction between CLC-5
and NHERF2, we incubated MBP-ClC-5 with GST-NHERF2 in vitro.
TheMBP-ClC-5was recovered and then run on aWestern blot that was
probed with anti-NHERF2. GST-NHERF2 incubated with MBP alone
as a negative control showed no interaction, whereas in the lane with
MBP-ClC5 there was a single band at 80 kDa that corresponds to
GST-NHERF2 (Fig. 2G). Interestingly, ClC-5 has a potential PDZ bind-
ing motif (ESILFN) from6 to3 position in the last 6 amino acids of
the C terminus that could potentially interact with PDZ proteins. Dele-
tion of the 5 terminal amino acids of ClC-5 (MBP-PDZ) did not alter
the binding toNHERF2 (Fig. 2G), demonstrating that NHERF2 binds to
an internal motif in the ClC-5 cytosolic tail (see Ref. 6). Fusion protein
controls showed equal amounts of MBP, MBP-ClC-5, and MBP-PDZ
in the reactions (Fig. 2H ).
Subcellular Localization of NHERF1 andNHERF2 inOKCells—Elec-
tron microscopy revealed that, in OK cells, NHERF1 was localized pre-
dominantly to the brush border membrane (Fig. 3A and inset), whereas
NHERF2 was associated primarily with intracellular membranes in the
proximity of the apical membrane, a distribution pattern similar to that
observed for NHERF2 in the mouse and human (Fig. 3, B–D).
Effect of NHERF2 onClC-5 Currents—ClC-5 binds to the PDZ2mod-
ule of NHERF2, which could leave the PDZ1 domains free to dimerize,
thereby concentrating ClC-5 protein at the cell surface. To establish
whetherNHERF2 had any effect on the cell-surface density of ClC-5, we
co-injected Xenopus oocytes with cRNA for ClC-5 and NHERF2 and
performed standard two-electrode voltage clamp experiments. The
presence of NHERF2 caused no change in the size of the currents medi-
ated by ClC-5 in the presence of NHERF2 (n 3, 38–39 oocytes, Fig. 4,
A and B).
Roles of NHERF2 and NHERF1 in Albumin Endocytosis—If the inter-
action betweenClC-5 andNHERF2 is physiologically relevant, silencing
endogenous NHERF2 should affect the rate of albumin uptake because
FIGURE 3. Distribution of NHERF1 and NHERF2 in polarized OK cells. A, electronmicro-
graph showing that NHERF1 is primarily expressed in the microvilli of OK cells (inset shows
cluster of microvilli). B–D, electron micrographs showing that NHERF2 (arrows) is primarily
associated with intracellular membranes below the apical membrane. Panel B shows a sec-
tion through the apical surface of the cell, whereasC andD showglancing sections through
the subapical region (note the subapical junctional complexes between adjacent cells inD).
FIGURE4.NHERF2doesnotalter thecurrentamplitudeofClC-5.A, representativeCl
currents recorded from oocytes expressing ClC-5 in the absence (control) and presence
of NHERF2 and water injected. To evoke inward Cl currents, oocytes were held at70
mVand step-depolarized to voltages between30 and80mV in 10-mV increments. B,
bar graph representing theCl current amplitudeat80mV recorded fromoocytes that
werewater injected (control), expressingClC-5 aloneand in combinationwithNHERF2 (I)
relative to the average of control Cl current amplitude (recorded fromoocytes express-
ing only ClC-5) (I0). Data are expressed as the mean	 S.E. of 38–39 oocytes from three
separate batches.
FIGURE 5. Silencing NHERF2 inhibits albumin uptake. A, Western blot analysis of cells
transfected with pSHAG 274 and pSHAG 361 shows a decrease in NHERF2 expression
compared with cells transfected with vector control (pSHAG-FF). No change in NHERF1
protein expression was observed. B, silencing NHERF2 with pSHAG 274 and pSHAG 361
causes a significant decrease in albumin endocytosis relative to cells transfected with
vector (pSHAG-FF) control (*, p 0.05; n 4).
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of the obligate role of ClC-5 in albumin uptake.We therefore performed
albumin uptake experiments on OK cells transiently transfected with
plasmids expressing small interference RNA directed against NHERF2.
We used two different silencing plasmids (pSHAG274 and pSHAG361)
(47) that target different regions of the NHERF2 open reading frame,
and both these plasmids caused significant reductions in endoge-
nous NHERF2 to 64.0	 5.9% and 72.5	 7.5% of control values (Fig.
5A), whereas the levels of NHERF1 remained unchanged. Impor-
tantly, silencing of NHERF2 with either pSHAG274 or pSHAG361
resulted in significant decreases in TR-albumin uptake to 74 	 3%
and 67 	 4%, respectively (n  3, p  0.05) of the control levels
(pSHAG-FF) (Fig. 5B). As reported previously, the transfection effi-
ciencies of OK cells in these experiments are typically of the order of
50% (22), therefore, the 30% reduction we observe in TR-albu-
min uptake by the total population of cells is a significant underes-
timate of the true reduction in TR-albumin uptake by those cells that
express small interference RNA directed against NHERF2. This is
confirmed in the confocal experiments performed on albumin
uptake in single OK cells (cf. Fig. 7 below).
We next investigated the effects of silencing NHERF1 on albumin
uptake. OK cells were transiently transfected with plasmids expressing
small interference RNA (EBP114 and EBP248) against NHERF1 that
resulted in a pronounced reduction in the levels of NHERF1 to 73.3 	
5.7% and 65.6 	 7.7% of control levels with no change in the levels of
NHERF2 (Fig. 6A). When NHERF1 was silenced, there were significant
increases in albumin uptake to 118 	 6% compared with control for
EBP114 and 120 	 4% for EBP248 (n  3, p  0.05, Fig. 6B). Albumin
FIGURE 6. Silencing NHERF1 increases albumin uptake but does not involve
cAMP. A, Western blot analysis of cells transfected with EBP114 and EBP248 shows a
decrease in NHERF1 expression compared with cells transfected with vector control
(pSHAG-FF). No changes in NHERF2 protein expression were observed. B, in cells
where NHERF1 was silenced with either EBP114 or EBP248 there was a significant
increase in albumin endocytosis relative to cells transfected with vector control
(pSHAG-FF) (*, p 0.05; n 4). C, pre-treatment of OK cells with 8-Br-cAMP (100 M)
causes a significant decrease in albumin uptake in both control cells (pSHAG-FF) and
cells transfected with EBP114. Despite the increase in albumin uptake when NHERF1
was silenced, there was no change in the percent inhibition by 8-Br-cAMP. The per-
cent inhibition of total albumin uptake was 21.9	 3% for the pSHAG-FF and 21.8	
3% when NHERF1 was silenced (n  3).
FIGURE 7. Silencing NHERF1/2 alters the number of albumin endocytic vesicles.OK
cells co-transfected with silencing constructs and GFP were exposed to TR-albumin (50
g/ml) for 2 h, and confocal images were obtained. The number of albumin clusters per
cell was then calculated to determine the effects of silencing NHERF1/2 on albumin
uptake in single cells. A, in cells silenced for NHERF1 (EBP114 and EBP248) there was a
significant increase in albumin clusters per cell (136.9 	 0.9% and 126.3 	 1.0%,
respectively; n  3) compared with cells transfected with GFP and pSHAG-FF
(102.5 	 1.3%; *, p  0.05; n  3). In cells transfected with GFP and pSHAG274 or
pSHAG361 therewas a significant decrease in albumin clusters per cell (23.8	 0.5% and
35.4 	 0.8%, respectively; *, p  0.05; n  3). B, dual wavelength confocal imaging of
representative single cells showing changes in the number of albumin endocytic vesi-
cles. The GFP channel indicating transfected cells (left column) and the corresponding
TR-albumin uptake images (right column). Cells were transfected with either pSHAG-FF
(control), EBP114 (NHERF1 silenced), or pSHAG361 (NHERF2 silenced).
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uptake by OK cells is inhibited by cAMP, an effect that has been attrib-
uted to inhibition of NHE3 (11). We therefore investigated whether
8-Br-cAMP could inhibit the increase in albumin uptake observed fol-
lowing silencing of NHERF1. Despite the 20% increase in albumin
uptake, the percentage inhibition of albumin uptake by 8-Br-cAMP
remained unchanged at 21.9 	 3% and 21.8 	 3% (n  3) in cells
transfected with pSHAG or EBP114, a value that was not significantly
different from untransfected cells (Fig. 6C ).
We then used confocal microscopy to confirm the changes in
albumin uptake in response to silencing NHERF1/2 using previously
described methods. OK cells co-transfected with GFP and the silenc-
ing plasmids were exposed to TR-albumin, and the fixed cells were
examined by dual-wavelength confocal microscopy. Albumin is
taken up into endocytic vesicles that can be readily visualized at the
plane of the apical membrane and quantitated. In control cells there
was an average of 18	 1 vesicles per cell, which were standardized to
100% (Fig. 7, A and B, n 30 cells from three separate experiments).
In cells where NHERF1 was silenced by transfection with EBP114
and EBP248 there was a significant increase in the number of endo-
cytic vesicles to 136.9 	 0.9% and 126.3 	 1.05% of control, respec-
tively (Fig. 7, A and B, n  3, p  0.05). In contrast, silencing
NHERF2 by transfection with pSHAG274 and pSHAG361 resulted
in a pronounced decrease in albumin containing endocytic vesicles
to 23.7	 0.5% and 35.4	 0.8% of control, respectively (Fig. 7, A and
7B, n  30 cells from three separate experiments, p  0.05). These
data obtained in single cells confirm the effects observed using albu-
min uptake in entire monolayers of transfected cells.
Effect of Silencing NHERF1/2 on Cell-Surface Levels of ClC-5—The
availability of ClC-5 to the endocytic complex is a limiting factor for
albumin uptake, therefore the decrease in albumin uptake when
NHERF2 is silenced should be paralleled by a decrease in the surface
levels of ClC-5. Indeed, silencing NHERF2 with either pSHAG274 or
pSHAG361 resulted in a significant decrease in ClC-5 at the cell surface
(Fig. 8,A andB, 52	 6% and 62	 10%, respectively), comparedwith the
pSHAG control (n 4, p 0.05). Conversely, the increase in albumin
uptake due to silencing of NHERF1 should be paralleled by an increase
in cell-surface levels of ClC-5. When cells were transfected with either
EBP114 or EBP248 to silence NHERF1, we observed a significant
increase in cell-surface levels of ClC-5 (Fig. 8, A and B, 156	 14% and
193 	 21%, respectively) compared with pSHAG control (n  3, p 
0.05). Under the different conditions, there was no change in the total
amount of ClC-5 in the cell lysate (Fig. 8A).
Membrane Association of NHERF1 and NHERF2 in Response to
Albumin—Both NHERF1 and NHERF2 are abundant in the cyto-
plasm and must be recruited to the cell membrane as required. Our
model predicts that more NHERF2 should associate with the mem-
brane in the presence of albumin to facilitate the assembly of the
endocytic complex in parallel with the increase in ClC-5 that we have
previously demonstrated (36). If NHERF1/2 physically associate with
the plasma membrane then they should be detected in association
with cell-surface proteins. We therefore performed surface biotinyl-
ation of OK cells after treating the cells in the presence or absence of
a normal tubular concentration of albumin (10 g/ml) for 2 h at
37 °C. Biotinylated proteins were then isolated after cell lysis, and the
association of NHERF1/2 with biotinylated plasma membrane pro-
teins was determined byWestern blotting. Densitometric analyses of
the Western blots revealed (Fig. 9, A and B) that albumin caused a
significant increase in NHERF2 associated with cell-surface proteins
(125.0 	 5.2% of control levels, n  3, p  0.05). In contrast, the
levels of NHERF1 were significantly decreased to 67.0 	 7.2% of
control levels (n  3, p  0.05) following exposure to albumin.
Importantly, there was no change in the levels of either NHERF1 or
NHERF2 in the total cell lysate (Fig. 9A).
Recruitment of NHERF1/2 to the plasma membrane typically involves
associationwith ezrin via the C-terminal ezrin binding domain (24).We
therefore investigated the effects of deleting the ezrin binding domains
(EZR) of NHERF1 and NHERF2 on albumin uptake. Overexpression
of NHERF1EZR resulted in significant increases in albumin uptake
(Fig. 9C, 124.3 	 2.3%, n  3, p  0.05). In contrast NHERF2EZR
significantly reduced albumin uptake to 80.3 	 3.9% of control levels
(n 3, p 0.05).
FIGURE 8. Silencing NHERF1 and NHERF2 alters
the cell-surface amount of ClC-5. A, representa-
tive Western blot showing the effect of silencing
NHERF1/2 on the levels of cell-surface ClC-5. OK
cells were transfectedwith either NHERF1 EBP114
and EBP248 or pSHAG274 and pSHAG361 to
silence NHERF1 or NHERF2, respectively. The cell-
surface biotinylated fractions were harvested and
Western blotted using ClC-5 antibody. Under all
conditions, the level of ClC-5 in the total cell lysate
was unaltered. B, bar graph showing the levels of
ClC-5 at the cell-surface fraction. Silencing
NHERF1 resulted in a significant increase in ClC-5
(156	14%and193	21%of control;n3; *,p
0.05). In contrast, silencing NHERF2 significantly
decreased the levels of ClC-5 to 52	 6%and 62	
10% of control (n 3; *, p 0.05).
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DISCUSSION
It is increasingly clear that the obligate role of ClC-5 in albumin
uptake involves the assembly of the albumin endocytic complex and its
association with the cytoskeleton (21, 22, 48). In the current study, we
have started to address the protein-protein interactions involved in this
process and focus on the role of NHERF PDZ scaffolds. We reveal a
novel role for NHERF2 in albumin uptake by OK cells that is mediated
by direct interaction with ClC-5. We also show that NHERF1 in the
microvillus can influence the rate of albumin uptake, possibly by both
limiting the availability of NHE3 to the albumin endocytic compart-
ment and altering cell-surface levels of ClC-5.
OK cells are the accepted cell culture model for albumin uptake by
the proximal tubule. Compared with the native proximal tubule, OK
cells do not have a dense brush border, and their intravillar regions are
less morphologically complex (49). However, they retain megalin/
ClC-5- and NHE3-dependent albumin uptake pathways (36, 50), and
NHE3 is reported to traffic from the microvilli to the intravillar regions
(34). Importantly, the distribution of NHERF1 in the microvilli domain
and NHERF2 in regions between the microvilli that we report corre-
sponds to their distributions in the mouse and human proximal tubules
(29, 31), thus OK cells are a suitable model for the investigation of the
molecular basis of receptor-mediated albumin uptake (see Ref. 2).Many
studies investigating the role of NHERF1/2 and NHE3 in OK cells rely
on overexpression of these proteins (34, 51). It is important to note that
the current study was performed using OK cells that endogenously
express NHERF2. Thus, these data reflect genuine protein interactions
under native conditions.
ClC-5 co-immunoprecipitated NHERF2 but not NHERF1 from OK
cell lysate. This is consistent with the spatial heterogeneity of ClC-5 and
NHERF1 in the proximal tubule. Although ClC-5 co-localizes with
albumin in OK cells and Rab4 in recycling endosomes (46), NHERF1 is
present at the microvillus (31), thus it is unlikely that these two proteins
interact in vivo. ClC-5 binds the PDZ2 module of NHERF2, and the
binding does not involve the final amino acids ESILFN at the C termi-
nus. This indicates that, similar toNHE3, ClC-5 interacts withNHERF2
via an internal binding site (20). The fact that NHERF2 had no effect on
ClC-5 current magnitude in Xenopus oocytes argues against the
NHERF2-ClC-5 complex dimerizing to increase the cell-surface density
of ClC-5, as has been reported for NHERF1 and CFTR (52). Alterna-
tively, NHERF2 may act to stabilize ClC-5 at the cell membrane in a
cell-type-specific manner involving interacting proteins that are not
present in oocytes.
Albumin uptake involves interactions with the cytoskeleton (6, 23)
and increases both the cell-surface levels of ClC-5 (36) and the num-
ber of actin clusters at the apical membrane (21). We now show that
the presence of albumin also increases the levels of NHERF2 associ-
ated with the plasma membrane. Furthermore, silencing NHERF2
caused significant reductions in surface ClC-5, the number of actin
clusters, and albumin uptake. Under conditions where albumin
uptake is reduced, one prediction would be a reduced rate of inter-
nalization of ClC-5 paralleled by an increased residence time of
ClC-5, reflected by an increase in surface expression. The fact that
we see a reduction in the degree of albumin uptake and surface ClC-5
suggests that an accessory protein such as NHERF2 is required to
maintain ClC-5 at the membrane. Taken together these data support
a model in which ClC-5 plays a key role in nucleating the formation
of the endocytic complex, presumably by mechanisms that involve
tethering of the complex via NHERF2 to the actin cytoskeleton. The
inhibition of albumin uptake upon overexpression of an ezrin bind-
ing-deficient NHERF2 further demonstrates the importance of the
interaction between NHERF2 and ezrin interaction in this process.
It has been suggested that increased levels of cAMP reduce albu-
min uptake by inhibiting NHE3 (11). cAMP inhibits NHE3 via an
NHERF1-ezrin-protein kinase A complex (53) and basal level phos-
phorylation of NHE3 by protein kinase A is reported in proximal
tubule cells (54). Therefore, we initially attributed the increase in
albumin uptake following silencing of NHERF1 to disruption of the
normal interaction between NHERF1-ezrin and protein kinase A,
leading to a reduction in the tonic inhibition of NHE3. Silencing
NHERF1, however, did not prevent the cAMP-mediated inhibition
of albumin uptake, indicating that this effect of cAMP does not
involve NHERF1. The fact that NHERF1 is restricted to the
microvilli and not present at the site of albumin uptake is consistent
with this result. Furthermore, there are no reports of albuminuria in
NHERF1 knock-out mice. Finally, baseline NHE3 activity in OK cells
is not altered by overexpression of an ezrin binding-deficient
NHERF1 (55), which also argues against tonic inhibition of NHE3
affecting albumin uptake. Thus, our findings show that cAMP does
not decrease albumin uptake in OK cells by inhibiting NHE3 via
NHERF1.
FIGURE 9.Albuminalters the levels ofNHERF1/2 associatedwith the cell surface.OK
cellswere exposed to albumin (10g/ml) for 2 h at 37 °C, and the cell-surface-associated
fractionwas isolatedusing surface biotinylation.A, representativeWesternblot showing
the changes in cell-surface-associatedNHERF1/2 in response to treatmentwith albumin.
However, the level of NHERF1 and NHERF2 in the total cell lysate was unaltered. B, bar
graph showing that, in thepresenceof albumin, the levels ofNHERF1 associatedwith the
plasmamembranewere significantly decreased (67	 7.2%;n 3; *,p 0.05) compared
with cells not exposed to albumin. In contrast, NHERF2 levels significantly increased at
the cell surface comparedwith control (125	5.2%;n3; *,p0.05). However, the level
of NHERF1 and NHERF2 in the total cell lysate was unaltered. C, bar graph showing the
effects of overexpression of ezrin binding-deficient NHERF1/2 on albumin uptake. In
cells overexpressing NHERF1EZR, albumin uptake was increased to 124.3	 2.3% (n
3; *, p 0.05). In contrast, when NHERF2EZR was overexpressed albumin uptake was
significantly reduced (80.3	 3.9%; n 3; *, p 0.05).
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How else could silencing of NHERF1 increase albumin endocytosis?
NHE3 has a key role in albumin uptake, and, similar to ClC-5, its avail-
ability to the endocytic complex must be a limiting step in albumin
uptake. In OK cells, NHE3 traffics from themicrovillus to the intravillar
cleft (34). It has been suggested that stimulated endocytosismay require
changes in the mobility of NHE3 by mechanisms that involve
NHERF1/2 (34). Importantly, at themicrovillarmembrane, a significant
fraction of NHE3 is immobilized; that is, it is tethered to the actin
cytoskeleton via proteins such as NHERF1 or small GTPases (33, 34).
Based on these data, we can propose a model in which silencing
NHERF1 simply increases the mobile fraction of NHE3 available to the
intravillar cleft, thereby accelerating albumin uptake. Albumin also
caused a significant reduction in plasma membrane-associated
NHERF1 possibly allowing increased mobility of NHE3. Similarly, the
ezrin binding-deficient NHERF1 may be exerting a dominant negative
effect on the normal tethering of NHE3 to the cytoskeleton thereby
increasing its mobility. The link between NHERF1 and albumin uptake
was further strengthened by the increase in cell-surface ClC-5 observed
when NHERF1 was silenced. Our model predicts that, as an essential
component of the endocytic complex, the increase in albumin uptake
must be accompanied by a parallel increase in ClC-5. Conversely, in
cells where NHERF2 is silenced, ClC-5 levels are reduced as less of the
endocytic complex is formed.
The data from the current study clearly support a model in which
the rate of albumin endocytosis is governed by the availability of key
proteins that constitute the endocytic complex. At the plasma mem-
brane, ClC-5 acts as a key structural element in the macromolecular
endocytic complex independent of any ion transporting activity.
This is particularly relevant given the recent findings that ClC-5
functions as a Cl/H antiporter rather than a Cl channel (16, 17),
which raise some questions as to the role of ClC-5 as an anion shunt
in the albumin uptake process. Our data show how PDZ scaffolds can
direct the activity of spatially discrete functional compartments
within the apical domain of epithelial cells. Albumin increases the
association of NHERF2 with the plasma membrane, where it links
ClC-5 to ezrin to anchor the endocytic complex. In contrast,
NHERF1 possibly plays a negative regulatory role in controlling the
availability of NHE3 to the endocytic complex. Albumin reduces the
association of NHERF1 with the plasma membrane, which could
increase availability of NHE3 to the endocytic compartment and
thereby increase levels of ClC-5 and albumin uptake. It remains to be
determined whether ClC-5 and NHE3 are present in the same mac-
romolecular complex. It is possible that NHERF2 could dimerize and
link ClC-5 and NHE3. However, it has been shown that megalin and
NHE3 interact via their C termini (56), and as a result, megalin may
obscure the internal NHERF binding site on NHE3. It is also possible
that another albumin uptake compartment exists that depends on
NHE3 but not ClC-5 (48). Further biochemical/biophysical studies
are required to elucidate the exact protein-protein interactions that
mediate the formation of the albumin endocytic complex. In conclu-
sion, our data suggest that albumin initiates the formation of the
macromolecular complex that mediates its own internalization. This
study highlights novel roles for the PDZ scaffolds NHERF1/2 in the
constitutive uptake of albumin by the proximal tubule and extends
our understanding of the molecular basis for the obligate role of
ClC-5 in this process. From a clinical perspective, such data provide
a mechanism that links NHE3 activity and mobility directly to albu-
min uptake, an issue that is relevant in terms of the Na retention
and proteinuria that frequently occurs in kidney diseases such as
diabetic nephropathy (57, 58).
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